Exploring the miR-19a/PTEN Interaction: Insights into Tumor Biology and Treatment Strategies

MicroRNAs (miRNAs) play a crucial function in the complex regulatory networks that control cancer progression. Among them, miR-19a has become a significant oncogenic player, especially via its engagement with the tumor suppressor phosphatase and tensin homolog (PTEN), leading to aberrant activation of the PI3K/AKT signaling cascade. This review critically examines the mechanistic underpinnings of the miR-19a/PTEN axis, highlighting its impact on tumor formation and spread and therapy resistance across various malignancies. This explores the practical consequences in a clinical context of miR-19a as a possible biomarker for cancer prognosis and its modulation as a treatment approach. Furthermore, this review discusses the interplay among miR-19a and other molecular regulators within the tumor microenvironment, shedding light on new avenues for targeted interventions. Given the mounting evidence linking miR-19a dysregulation to aggressive cancer phenotypes, understanding its intricate regulatory framework landscape could pave the way for novel therapeutic breakthroughs.